Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
BBNX compared with PALI: revenue, margins and what each company keeps, and the suppliers and customers both name
BBNX
Beta Bionics, Inc.
Change
Mkt cap
Revenue
Revenue
PALI
Palisade Bio, Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
BBNX
Beta Bionics, Inc.
vs
PALI
Palisade Bio, Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Supply-chain overlap
Desk
News
Calendar
Saved
Search
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only BBNX
0
None
Shared
0
No disclosed counterparties: BBNX.
Only PALI
2
—
Giiant Pharma
unlisted
supplier
—
Newsoara
unlisted
customer
Role chip = supplier or customer
—
= no ticker (unlisted)
Source: SEC EDGAR
BBNX
Beta Bionics, Inc.
Change
15.94
▼
−4.81%
· post 15.94
Mkt cap
$779.6M
Revenue
$36M
Q3 FY26
Revenue
$100M
FY25
PALI
Palisade Bio, Inc.
Change
1.11
▼
−4.56%
· post 1.11
Closed
Nov 2 '26
Mkt cap
$202.2M
Revenue
$500,000
Q2 FY26
Revenue
—
vs
Compare
Closed
Nov 2 '26
BBNX
Beta Bionics, Inc.
vs
PALI
Palisade Bio, Inc.
15.94
▼
−4.81%
post 15.94
Price
1.11
▼
−4.56%
post 1.11
$779.6M
Mkt cap
$202.2M
Q3 FY26
$36M
Revenue
$500,000
Q2 FY26
FY25
$100M
Revenue
—
Change
Change
BBNX
15.94
▼
−4.81%
vs
PALI
1.11
▼
−4.56%
Closed
Nov 2 '26